Health Condition 1: J454- Moderate persistent asthma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: patients with bronchial asthma
Exclusion criteria
Exclusion criteria: Chronic obstructive pulmonary disease,Tuberculosis,Renal failure,Cancer, Coronary artery disease,Stroke,Musculoskeletal chest deformities,Respiratory tract infections within in the previous 6 weeks,Chronic bleeding in the nose,Epilepsi,Bed ridden patient,Pregnant women,Acute breathing difficulty
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in pulmonary function,quality of life, and compliance to antiasthmatic medications among patients with bronchial asthmaTimepoint: Pulmonary function,quality of life and compliance to antiasthmatic medications among bronchial asthma patients will be assessed at 1 month, 3 months and 6 months after the interventional program | — |
Secondary
| Measure | Time frame |
|---|---|
| Decrease in the number of asthmatic attacks and barriers to asthmatic medication adherence after intervention among bronchial asthma patientsTimepoint: After 1st month,3rd month and 6th month of intervention | — |
Countries
India
Contacts
University of Kerala